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Abstract 
Background: Food allergy is a common cause of anaphylaxis, but the incidence of 
anaphylaxis in food allergic people is unknown.  
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Methods: We undertook a systematic review and meta-analysis, using the inverse 
variance method. Two authors selected studies by consensus, independently extracted 
data and assessed study quality using the Newcastle-Ottawa assessment scale. We 
searched Medline, Embase, PsychInfo, CINAHL, Web of Science, LILACS and AMED 
between January 1946 and September 2012, and recent conference abstracts. We 
included registries, databases or cohort studies which described the number of food 
anaphylaxis cases in a defined population and time period, and applied an assumed 
population prevalence of food allergy. 
 
Results: We included data from 34 studies. There was high heterogeneity between 
study results, possibly due to variation in study populations, anaphylaxis definition and 
data collection methods. In food allergic people, medically-coded food anaphylaxis had 
an incidence rate of 0.14 per 100 person years (95% CI 0.05, 0.35; range 0.01, 1.28). In 
sensitivity analysis using different estimated food allergy prevalence, the incidence 
varied from 0.11 to 0.21 per 100 person years. At age 0-19 the incidence rate for 
anaphylaxis in food allergic people was 0.20 (95%CI 0.09, 0.43; range 0.01, 2.55; 
sensitivity analysis 0.08, 0.39). At age 0-4 an incidence rate of up to 7.00 per 100 
person years has been reported. In food allergic people, hospital admission due to food 
anaphylaxis had an incidence rate of 0.09 (95% CI 0.01, 0.67; range 0.02, 0.81) per 
1000 person years; 0.20 (95% CI 0.10, 0.43; range 0.04, 2.25) at age 0-19 and 0.50 
(0.26, 0.93; range 0.08, 2.82) at age 0-4.  
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Conclusion 
In food allergic people, the incidence of food allergic reactions which are coded as 
anaphylaxis by healthcare systems is low at all ages, but appears to be highest in 
young children. 
 
Introduction 
Food allergy affects up to 10% of children and 2-3% of adults, has a significant quality 
of life impact and appears to be increasing in prevalence in some countries. (1-3)   Food 
allergy is the commonest cause of anaphylaxis, however the precise risk of anaphylaxis 
for food allergic people is not known. Uncertainty about the absolute level of risk 
associated with food allergy may be an important contributor to wider uncertainties over 
service provision for food allergy, food labelling legislation and allergen management 
strategies. In order to quantify the risk of anaphylaxis for food allergic people, we 
undertook a systematic review and meta-analysis. We estimated the incidence rate of 
self-reported anaphylaxis, of medically-coded anaphylaxis and hospital admission for 
food anaphylaxis in a food allergic individual. As part of the same project, we estimated 
the incidence rate of fatal anaphylaxis and have reported this elsewhere (4) . We 
compared these risks with other age-specific risks for people living in the United States 
or Europe. We undertook subgroup analyses for young people (aged 0-19) with food 
allergy, and for peanut allergic people. In view of the uncertainty about food allergy 
prevalence in different populations, we undertook sensitivity analysis to explore the 
effect of varying food allergy prevalence estimates, on food anaphylaxis incidence.  
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Methods 
Data sources 
This review was carried out and reported in accordance with the PRISMA guidelines for 
systematic reviews and meta-analyses (5). We searched Medline, Embase, PsycINFO, 
Web of Science, Allied and Complementary Medicine (AMED), Latin American and 
Caribbean Health Science Information database (LILACS) and Cumulative Index to 
Nursing and Allied Health Literature (CINAHL) for articles published between January 
1946 and September 5th 2012 which described food anaphylaxis incidence – the 
Medline search strategy has been published elsewhere (4), and similar searches were 
used for other databases. We searched abstracts from the 2011 and 2012 meetings of 
the American Academy of Asthma Allergy and Immunology (AAAAI) and the European 
Academy of Allergy and Clinical Immunology (EAACI) using ‘food allergy’ and 
‘anaphylaxis’. We searched US national data (CDC Wonder, Centers for Disease 
Control and Prevention) and European Union-27 data (Eurostat, European 
Commission) for incidences of other sudden or emergency events. There was no 
registered protocol for this review, but the methods and analyses were planned a priori. 
No language restrictions were made, and we planned to include non-English papers if 
they met our inclusion criteria. 
 
Study selection 
Two authors (TU, RJB) independently screened titles and abstracts, and selected 
studies by consensus. We reviewed reference lists of included studies and review 
articles to identify any further studies. Inclusion criteria were: (i). Study design. 
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Prospective or retrospective registries, databases or cohort studies. (ii). Participants. 
People with a medically diagnosed food allergy, or a defined population where an 
assumed population rate of food allergy could be applied. (iii). Follow up. To enable 
calculation of total person-years of observation, we included studies that specified either 
total population and duration of data collection, or anaphylaxis incidence rate. (iv). 
Outcomes. We included reports of number of food anaphylaxis events during the follow 
up period. Exclusion criteria were: (i). food allergic reactions reported were not 
anaphylactic, or severity was not defined; (ii). time period not defined; (iii). population in 
which food anaphylaxis cases occurred could not be quantified. Studies needed to 
satisfy all 4 inclusion criteria and none of the exclusion criteria, to be included in the 
review. Where the population number was not described in the study, we derived total 
populations and populations aged 0-19 using regional public health databases. Where 
necessary we contacted authors for data clarification or original datasets. 
 
Data extraction 
Two authors (TU, RJB) independently extracted data, and quality assessed the included 
studies. Differences were resolved by discussion. When available, we separately 
extracted data for younger people (age 0-19), and those with peanut allergy. We 
estimated incidences for the total food allergic population, and subgroups of aged 0-19 
years and peanut allergy. Where studies were restricted to a population aged < 19, data 
were only used for the 0-19 subgroup, and likewise for peanut allergy. For quality 
assessment we used the Newcastle-Ottawa quality assessment scale for cohort studies 
with one modification.(6)  Under the criterion ‘was follow-up long enough for outcomes 
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to occur’ we considered studies with at least 20 cases of food anaphylaxis to satisfy this 
criterion. We separately recorded an extra quality criterion - whether diagnostic criteria 
for anaphylaxis used in each study were consistent with the consensus NIAID/FAAN 
definition (7). For studies of hospital admissions, we judged anaphylaxis definitions to 
be consistent with NIAID/FAAN criteria if they used ICD codes for anaphylaxis.(7) 
Studies were considered high quality if Newcastle-Ottawa score was at least 4, and 
anaphylaxis definition was consistent with the consensus definition. For analyses where 
all studies scored less than 4, we undertook subgroup analysis excluding the poorest 
quality studies (ie score <2). 
 
Data synthesis 
For each study, number of events and total person-years of follow-up were extracted, 
and incidence rate was calculated as number of cases per 100 or 1000 person years. 
Rates were pooled across studies using the natural logarithm of the occurrence rate 
and its standard error (estimated using 1/√events) based on a random effect model 
using the generic inverse variance method (STATA version 12 IC, Stata Corporation). 
Heterogeneity was assessed using I2. For meta-analyses including ≥10 studies, we 
assessed publication bias using Funnel plots. We conducted meta-analysis even if 
significant heterogeneity was seen between study estimates, but explored possible 
reasons in sensitivity analyses, including study quality. For calculations we estimated 
the population food allergy prevalence as 3% overall, 3.9% for a 0-19 year old, 1% for 
peanut allergy, but explored the effect of different prevalence estimates in sensitivity 
analyses due to the considerable uncertainty in the literature surrounding food allergy 
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prevalence in different populations. (2, 8-10) We assumed that all food anaphylaxis 
would occur in this population. We made no separate analysis of incidence according to 
sex, due to insufficient gender-specific data from included studies.  
 
Estimation of comparator risks 
We selected sudden unexpected occurrences with recent reliable population-based 
information as comparator risks using US and EU-27 data. Emergency department 
attendances for a motor vehicle accident (E810-E819, E958.5, E968.5, E988.5), total 
emergency department attendance rates, and attendances due to an injury (E800-E848, 
E850-E869, E880-E929) were extracted from National Center for Health Statistics data 
for 2006-2008 (CDC Wonder, Centers for Disease Control and Prevention). Fatality 
data including murder (X85-Y09), fire (X00-X09), all accidents (V01-99 or W00-X59), 
lightning (X33) and all cause mortality were extracted from the same data source for 
2005-2007. European data using the same codes and time periods were extracted from 
Eurostat for the EU-27 population (Eurostat, European Union). The data used were not 
age-adjusted. 
 Results 
Our search identified 2552 original titles. Title screening yielded 459 abstracts, and 156 
full articles were reviewed for potential relevance. We identified 37 publications 
containing relevant data, and a further 5 publications from screening review articles and 
reference lists. Eight of these articles only reported fatal anaphylaxis events and were 
included in fatal anaphylaxis analyses reported elsewhere (4). The remaining 34 studies 
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contributed to the analyses reported herein. Search results are shown in Figure 1, and 
characteristics of included studies in Table 1. All included studies contributed to at least 
one meta-analysis. 
  
Incidence rate of self-reported food anaphylaxis in food allergic people 
We identified 10 studies including 9076 participants, where follow up data for the 
occurrence of food anaphylaxis in food allergic individuals were presented or could be 
derived.(11-20) Data for self-reported food anaphylaxis at all ages were only available 
from one study, where the estimated risk for a food allergic person was 8.59 (95% CI 
8.25, 8.94) per 100 person years. (18) For those aged 0-19, meta-analysis of data from 
all 10 studies gave an incidence of 4.93 (2.78, 8.74; range 0.60, 57.89) per 100 person 
years; one study (13) found an incidence of 9.27 (7.83, 10.98) per 100 person years for 
children aged 0-4 and for peanut allergic people meta-analysis of data from 4 studies 
gave an incidence rate of 2.64 (1.13, 6.17; range 1.64, 8.90) per 100 person years (15, 
16, 19, 20) (Figures 3A, 5A). Meta-analyses showed a high level of heterogeneity, but 
there was no evidence of publication bias (Figure E1).. 
 
Risk of medically coded food anaphylaxis in food allergic people 
We identified 13 surveys of medical attendances for food anaphylaxis, covering over 
19.9 million person years. (21-33)  Meta-analysis estimated the risk of medically-coded 
food anaphylaxis for a food allergic person as 0.14 (95% CI 0.05, 0.35; range 0.01, 
1.28) per 100 person years overall based on 9 studies (21, 24-30, 32); 0.20 (0.09, 0.43; 
range 0.01, 2.55) in those aged 0-19 based on 9 studies (21-23, 26, 28, 30-33); 0.37 
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(0.01, 17.07; range 0.03, 7.03) in those aged 0-4 based on 3 studies (21, 28, 32); and 
0.13 (0.04, 0.41; range 0.01, 0.54) in peanut allergy based on 6 studies (21-23, 28, 32, 
33) (Figures 2A, 3B, 4A, 5B). All meta-analyses showed high levels of heterogeneity. 
The study of Tejedor found a much higher rate of food anaphylaxis than other studies, 
in food allergic children aged 0-4, for unclear reasons. (32) In sensitivity analysis with 
different estimated food allergy prevalence (Table 2), the mean incidence rate varied 
from 0.07 to 0.21 per 100 person years; 0.08 to 0.39 for those aged 0-19; 0.14 to 0.72 
for those aged 0-4. Our study quality sensitivity analysis excluded studies with modified 
Newcastle-Ottawa score under 4/5 (21, 31, 33), or anaphylaxis definition inconsistent 
with the NIAID/FAAN consensus (7, 22, 24, 25, 27, 29, 31). Here we found an increased 
rate of medically-coded food anaphylaxis in the total food allergic population – 0.25 
(95% CI 0.06, 1.12; range 0.05, 1.28); in 0-19 year olds – 0.31 (0.08, 1.25; range 0.03, 
2.55); in 0-4 year olds – 1.35 (0.05, 37.57; range 0.23, 7.03) and for peanut allergy – 
0.18 (0.09, 0.36; range 0.11, 0.30) but heterogeneity of study outcomes remained 
significant. 
 
Risk of hospital admission due to food anaphylaxis in food allergic people 
We identified 11 studies which reported food anaphylaxis admission rates, covering 
over 120 million people observed over several years.(34-44) Meta-analysis estimated 
the risk of food anaphylaxis admission for a food allergic person as 0.09 (95% CI 0.01, 
0.67; range 0.02, 0.81) per 1000 person years overall, based on 4 studies (36, 39, 41, 
42); 0.20 (0.10, 0.43; range 0.04, 2.25) in those aged 0-19 based on 8 studies (34-37, 
40, 42-44); 0.50 (0.26, 0.93; range 0.08, 2.82) in those aged 0-4 based on 6 studies 
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(34-36, 40-42) and 0.08 (0.02, 0.36; range 0.02, 0.69) in peanut allergy based on 5 
studies (35, 37-39) (Figures 2B, 3C, 4B, 5C). All meta-analyses showed high levels of 
heterogeneity. In sensitivity analysis with different estimated food allergy prevalence, 
the incidence varied from 0.05 to 0.14 per 1000 person years; 0.08 to 0.39 for those 
aged 0-19; 0.19 to 0.98 for those aged 0-4. Our study quality sensitivity analysis 
excluded studies with a modified Newcastle-Ottawa score under 4/5 (35, 36), or 
anaphylaxis definition inconsistent with the NIAID/FAAN consensus (7, 35, 36, 44). 
Here we found increased incidence of food anaphylaxis admission in the total food 
allergic population - 0.16 (95% CI 0.02, 1.55; range 0.03, 0.81); in 0-19 year olds – 0.46 
(0.20, 1.07; range 0.04, 2.25); in 0-4 year olds – 0.98 (0.53, 1.82; range 0.08, 2.82) and 
in those with peanut allergy – 0.16 (0.03, 0.84; range 0.05, 0.69) but heterogeneity of 
study outcomes remained highly significant. 
 
Comparison of food allergy risks with other age-specific risks 
Figures E2A-B show the estimated annual incidence rate of food anaphylaxis for a food 
allergic person and a food allergic 0-19 year old, in comparison with incidence of other 
events for general US or European populations. The data suggest that the incidence of 
medically coded anaphylaxis for a food allergic person is greater than the general 
population incidence of accidental death, but is likely to be significantly lower than the 
incidence of Emergency Department attendance due to a motor vehicle accident. 
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Discussion 
In this systematic review we evaluated the incidence rate of anaphylaxis to food in 
people with food allergy, and compared our estimates with population incidence rates 
for other unexpected medical emergencies and causes of death. There was marked 
variation in the estimated rate of food anaphylaxis between studies, but at all ages and 
in all studies the incidence of medically coded anaphylaxis for food allergic people was 
low. We found evidence that food anaphylaxis rates are higher in preschool children 
with food allergy, where incidence rates varied significantly between studies, but were 
reported as up to 7 per 100 person years for medically-coded anaphylaxis, and 2.8 per 
1000 person years for hospital admission due to anaphylaxis. 
 
Food anaphylaxis is a medical emergency which occurs unpredictably and often 
involves young people. It causes alarm to the individual, family and carers due to its 
rapid clinical course, distressing symptoms and potential to cause a fatal reaction. 
Some people with food allergy and their families have restricted lives because of fear of 
anaphylaxis and fatal outcomes, which they may estimate to be more likely to occur 
than reality. (45) Accidental allergic reactions occur up to once per year in certain 
groups of food allergic people – our data suggest that severe, life-threatening allergic 
reactions occur much less frequently than this (13). The results of this study may help 
healthcare providers and their patients to more accurately appraise the risks of food 
allergy, and thereby make informed decisions about its management. 
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We did not identify a marked difference in food anaphylaxis rates in those aged 0-19 or 
in those allergic to peanut, but we did note that the highest rates of medically coded 
food anaphylaxis and hospital admission for food anaphylaxis were seen in preschool 
children. This contrasts with the pattern seen for fatal food anaphylaxis, which is most 
common in adolescents and young adults, but has a very low incidence rate in the 
preschool years (personal communication, Richard Pumphrey). It is unclear why food 
anaphylaxis is more common in preschool children, but possible reasons include the 
high prevalence of food allergy at this age, and the possibility that food anaphylaxis is 
more common preceding a diagnosis of food allergy than subsequently. The wide 
variation in rates between studies suggests that variable hospital admission criteria 
and/or coding may also be relevant. Previous work has identified that those with 
asthma, previous severe reaction, IgE binding to a diverse range of epitopes, deficient 
platelet activating factor acetyl hydrolase or serum angiotensin-converting enzyme may 
be at increased risk for food anaphylaxis. (46-48) One might expect the frequency with 
which a food is used as an ingredient, and allergen avoidance behaviour to also 
influence risk for individuals. We found some evidence to support this from two studies 
with different rates of self-reported anaphylaxis for allergy to different foods. There was 
a lower anaphylaxis rate for fish than for other food allergens in one study (49) and a 
lower rate for egg than milk in another (13). Those with food allergy secondary to 
inhalant sensitization (‘oral allergy syndrome’), without asthma, with previous mild 
reactions and beyond the preschool age group may be at lower risk of food anaphylaxis. 
It was not possible to separately assess food allergy caused by pollen-food cross-
reactivity in this study, due to limited data available in the included studies. More work is 
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needed to identify tools for risk stratification and risk reduction in patients with food 
allergy. (50) 
 
The limitations of this systematic review mainly relate to variations between studies in 
methods of data capture and classification of anaphylaxis, and limited information about 
food allergy prevalence in the populations studied. These sources of clinical and 
methodological heterogeneity were reflected in high levels of statistical heterogeneity in 
all analyses, which could not be explained by subgroup analysis according to age, 
specific food allergen or study quality. There is therefore some uncertainty about the 
precision of our risk estimates, so that the mean estimates should be interpreted with 
caution. The rate of self-reported anaphylaxis varied widely across studies, depending 
on the patient population enrolled and successfully followed up. Study quality was 
generally rated as low for studies of self-reported anaphylaxis, which generally occurred 
at less than 1 episode every 10 person years. There is a risk of over-reporting when 
relying on self-report of anaphylaxis and most of these studies enrolled patients from 
specialist allergy clinics, which may not be representative of all food allergic 
populations. The study of Gold reported a much higher rate of anaphylaxis than others, 
possibly due to a looser definition of anaphylaxis and small study size (14). Overall it is 
likely that studies of self-reported anaphylaxis over-estimate the true incidence of 
anaphylaxis, both due to the selected populations included, the nature of the methods of 
data collection, and the poor overall quality of included studies. 
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The rate of medically coded anaphylaxis also varied widely between studies, due in part 
to differing diagnostic criteria and sampling methods. In the highest quality studies, 
medically coded anaphylaxis occurred at up to 1 episode every 100 person years in the 
general population, 2.5 episodes at age 0-19, and 7 episodes at age 0-4. These data 
may under-estimate food anaphylaxis occurrence because not all anaphylaxis reaches 
medical attention – however the study quality was higher than for self-reported 
anaphylaxis, and severe anaphylaxis which needs medical attention is likely to be 
captured, at least where clinical coding can be relied upon. This means that the figures 
are likely to provide a reasonably accurate picture of the healthcare burden of food 
anaphylaxis for a given population. The study of Tejedor reported higher rates of food 
(but not peanut) anaphylaxis than others (32). The reason for this is unclear, although 
the authors used a larger number of databases to search for anaphylaxis cases than 
some other studies. The wide variations which we found in hospital admission rates for 
food anaphylaxis may be attributed to varied clinical coding, clinical practice and 
healthcare behaviours and food allergy prevalence between studies and over time. (41, 
42) Rates were highest in the Australian studies of Poulos and Mullins, which may 
reflect the high prevalence of food allergy in Australia (1, 40, 41). Overall rates are likely 
to be an underestimate, due to the known problems with reliance on clinical coding for 
data collection. The true incidence rate of food anaphylaxis for a food allergic person is 
likely to be higher than the estimate derived from studies of medically-coded 
anaphylaxis, but lower than the estimate derived from studies of self-reported 
anaphylaxis. 
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Given the limitations of population-based datasets and reliance on clinical coding of 
outcomes, it is likely that the most reliable estimates of food anaphylaxis incidence rate 
in food allergic people would come from detailed follow up and data capture/coding of 
representative groups of food allergic people. Although such datasets exist [13], the 
follow up studies which contributed to our meta-analyses were of uniformly poor quality, 
meaning that the rates of self-reported anaphylaxis may be unreliable. There is 
therefore a need for further longitudinal studies of representative food allergic 
populations to precisely assess the incidence rate of serious food allergic reactions.  
 
For the purpose of our study we estimated that the prevalence of food allergy is 3% for 
adults, 3.9% for children, and 1% for peanut allergy. Food allergy prevalence varies 
considerably between studies, (51) so a lower prevalence would increase the incidence 
rates, and vice versa. Food allergy and peanut allergy were found to be more prevalent 
than our estimates in some recent birth cohorts.(1, 52) We therefore undertook 
sensitivity analyses to explore the effect of variations in population food allergy 
prevalence on our estimates (Table 2). Overall the sensitivity analyses did not lead to 
marked differences in the overall pattern of estimated food anaphylaxis incidence rates. 
Variations in population prevalence of food allergy may therefore not be the most 
important reason for the wide variation we found in food anaphylaxis rates between 
studies. In Table 3, we present a summary of our assessment of the systematic review 
outcomes, which takes account of the sensitivity analyses and limitations discussed 
above. 
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In conclusion we have quantified the risk of food anaphylaxis for food allergic people, 
and found this to be low. With the exception of one small study with methodological 
limitations, all included studies reported food anaphylaxis incidence rate for food allergic 
people to be less than once every 10 person years. This information should help 
clinicians and their food allergic patients to make informed decisions with regard to risk 
management. These data also highlight the need to identify improved tools for 
anaphylaxis diagnosis and risk stratification in food allergy. 
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Table 1. Characteristics of included studies. 
  
Study Setting Population 
Case 
identification 
Anaphyla
xis 
definition 
consisten
t with 
NIAID/FA
AN 
Analyses 
*Quali
ty 
score 
Boyano-
Martine
z 2009 
(11) 
Allergy 
clinic, 
Spain 
2009 
88 children  
with 
immediate 
reaction to 
milk < age 1 
year 
Questionnaire 
about accidental 
allergic reactions 
in previous 12 
months. 
Yes Self-
reported 
anaphyla
xis 
2/5 
Clark 
2008 
(17) 
Allergy 
clinic, UK 
785 nut 
allergic 
children 
Prospectively 
recorded at 
annual/biannual 
follow up. 
Yes Self-
reported 
anaphyla
xis 
2/5 
 
Yu 
2006(16
) 
Allergy 
clinic, 
Canada 
2000-
2005 
252 peanut 
allergic 
children age 
4-17 years 
Questionnaire 
sent to patients 
identified from 
allergy clinic 
records. 
Yes Self-
reported 
anaphyla
xis 
1/5 
 
Cianfer
oni 
2004 
(12) 
Allergy 
clinic, 
Italy 
1994-
2003 
46 patients 
age 0-18 
with 
previous 
anaphylaxis  
Telephone 
survey of 
patients 
identified from 
clinic database.  
Yes Self-
reported 
anaphyla
xis 
1/5 
†Sicher
er 2000 
(53) 
National 
patient 
registry, 
US 1997-
2000 
5149 
voluntary 
registrants 
with nut 
allergy 
Self reported 
reactions 
subsequent to 
initial reaction. 
Yes Self-
reported 
anaphyla
xis 
2/5 
Gold 
2000 
(14) 
Allergy 
clinic, 
Australia 
1996-
1997 
68 children 
with a 
history of 
anaphylaxis 
Telephone 
interview of self 
reported 
symptoms. 
No Self-
reported 
anaphyla
xis 
2/5 
Vander 
Leek 
2000 
(15) 
Allergy 
clinic, US 
2000 
83 children 
with peanut 
allergy 
diagnosed 
<4 
Annual clinical 
review.  
No Self-
reported 
anaphyla
xis 
3/5 
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Nha 
2012 
(19)  
Allergy 
clinic and 
national 
survey 
combined
, Canada 
2004-
2009 
1411 
peanut 
allergic 
children age 
0-18 years 
Questionnaire 
survey of 
patients with at 
least 1 year of 
follow up data. 
Yes Self-
reported 
anaphyla
xis 
2/5 
Fleische
r 2012 
(13) 
Outpatien
t clinics, 
USA 
~2009 
512 infants 
age 3-15 
months with 
milk or egg 
allergy 
Prospective 
questionnaire 
survey of 
parents 
No Self-
reported 
anaphyla
xis 
3/5 
Neuma
n-
Sunshin
e 2012 
(20) 
Tertiary 
allergy 
clinics, 
Baltimore 
USA 
2008-
2009 
782 children 
aged 0-16 
with peanut 
allergy 
Retrospective 
chart review of 
clinic records 
No Self-
reported 
anaphyla
xis 
2/5 
Harduar
-Morano 
2011 
(30) 
Florida 
US, 
2005-
2006 
Non-federal 
ED 
attendances
, aged 0-17  
Healthcare 
records: ICD-9 
codes 995.6-
995.69, 995.0, 
or validated ICD-
9 based 
algorithm [35] 
Yes Medically 
coded 
anaphyla
xis 
4/5 
†Iribarre
n 2010 
(26) 
California 
US, 
1996-
2006 
HMO 
database 
 
Healthcare 
records: ICD-9 
codes 995.0, 
995.6, 999.4 
Insect 
sting/drug/anest
hetic excluded 
Yes Medically 
coded 
anaphyla
xis 
4/5 
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Simons 
2004 
(31) 
Canada, 
2000-
2001 
Canadian 
population 
aged 0-17  
 
Survey of 
pediatricians - 
cases had 
severe allergic 
reaction with 
sudden onset 
involving 1 or 
more body 
systems with 
typical allergy 
symptoms, 
resolving within 
24 hours. 
No Medically 
coded 
anaphyla
xis 
2/5 
Ross 
2008 
(28) 
US 2003 Representat
ive sample 
of ED 
attendances 
Healthcare 
records - either 
‘anaphylaxis’ 
mentioned in ED 
notes, or 
anaphylaxis 
symposium 
definition [9] 
Yes Medically 
coded 
anaphyla
xis 
4/5 
Decker 
2008 
(24) 
Olmsted 
County, 
US , 
1990-
2000 
Olmsted 
residents 
Healthcare 
records - two 
system 
involvement or 
hypotension or 
laryngeal edema 
No Medically 
coded 
anaphyla
xis 
4/5 
Braganz
a 2006 
(23) 
Brisbane, 
Australia 
1998-
2001 
ED 
attendances 
age 0-16 
Review of all 
case notes of 
children with 
ICD-9 discharge 
code of allergy, 
allergic reaction, 
anaphylactic 
shock/reaction, 
angioedema and 
urticaria, using 
ASCIA definition 
of anaphylaxis 
Yes Medically 
coded 
anaphyla
xis 
4/5 
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Peng 
2004 
(27) 
UK 
primary 
care 
database, 
1994-
1999 
UK 
population  
Healthcare 
record s - Oxford 
Medical 
information 
system Codes 
9779AK, 
9779AR, 
9894HA, 
9894HB, 
9894HN, 
9899AN, 9994, 
9994CC, 
9994MN, 
9994RM, or free 
text entry of 
Anaphylaxis 
No Medically 
coded 
anaphyla
xis 
4/5 
Helbling 
2004 
(25) 
Bern, 
Sweden 
1996-
1998 
Population 
of Bern 
Canton 
Healthcare 
records and 
survey of 
specialists: 
Severe systemic 
anaphylaxis with 
hypotension, 
unconsciousnes
s, shock 
identified using 
ICD-10 codes 
D69.0, T63.4, 
T78.0, T78.1, 
T78.2, T78.3, 
T88.2, T88.6, 
T88.7, X23 
No Medically 
coded 
anaphyla
xis   
4/5 
Bohlke 
2004 
(22) 
Washingt
on US 
1991-
1997 
HMO 
database 
age 0-17 
Healthcare 
records review 
after search by 
ICD code. Two 
system 
involvement or 1 
system + onset 
≤4 h after 
exposure + 
treated with a 
relevant 
medication 
No Medically 
coded 
anaphyla
xis   
4/5 
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Bock 
1992 
(21) 
Colorado 
USA 
1990-
1991 
ED 
attendances 
Emergency 
department 
survey – 
identified cases 
of probable food 
anaphylaxis 
involving 
respiratory 
and/or 
cardiovascular 
symptoms, or 
fatal food 
anaphylaxis 
Yes Medically 
coded 
anaphyla
xis   
 
3/5 
 
 
 
 
Yocum 
1999 
(29) 
Olmsted 
County, 
US 1983-
1987 
Olmsted 
residents 
Healthcare 
records - two 
system 
involvement, 
hypotension or 
laryngeal edema 
No Medically 
coded 
anaphyla
xis   
4/5 
Tejedor 
2011 
(32) 
Alcorcon, 
Spain 
2004-
2005 
Primary 
care and 
hospital 
records 
Healthcare 
records review: 
NIAID/FAAN 
symposium 
definition 
Yes Medically 
coded 
anaphyla
xis   
4/5 
Vetande
r 2012 
(33) 
Stockhol
m, 
Sweden 
2007 
ED 
attendances 
aged 0-18 
Healthcare 
records review 
after search 
based on ICD-
10 codes - two 
system 
involvement 
after exposure to 
a likely allergen, 
or 
hypotension 
alone after 
exposure to 
known allergen 
for the patient 
No Medically 
coded 
anaphyla
xis   
3/5 
Lin 
2008 
(37) 
New York 
State US 
1990 – 
2006 
NY state 
population 
age 0-19 
Statewide 
hospitalization 
database: ICD-9 
code 995.6  
Yes Anaphyla
xis 
admissio
n   
4/5 
A
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Poulos 
2007 
(41)  
Australia 
1993-
2005 
Australian 
population 
National 
hospitalization 
database: ICD-9 
995.0, 995.6, 
999.4, and ICD 
10 T78.0, 78.2, 
80.5, 88.6  
Yes Anaphyla
xis 
admissio
n   
4/5 
Mulla 
2007 
(39) 
Florida, 
US 2001  
Florida 
population 
Statewide 
hospitalization 
database: ICD-
9CM codes 
995.0/995-6-
995.69 
995.4/995.0 
(E930.0-931.0) 
Yes Anaphyla
xis 
admissio
n   
4/5 
Colver 
2005 
(35) 
United 
Kingdom 
1998-
2000  
UK 
population 
aged 0-15 
Survey of 
pediatricians: 
cardiorespiratory 
arrest, inotropes, 
>20ml/kg fluid 
resuscitation, >1 
dose 
epinephrine, or 
>1 dose 
nebulized 
bronchodilator 
No Anaphyla
xis 
admissio
n   
3/5 
Sheikh 
2000 
(42) 
England 
1991-
1995  
Total 
England 
population  
Hospital episode  
statistics 
searched for 
ICD codes 
995.0/ 999.4  
Yes Anaphyla
xis 
admissio
n   
4/5 
Mulla 
2011 
(38) 
Texas, 
US 2004-
2007 
Texas 
population 
aged 0-24 
Statewide 
hospitalization 
database: 
discharge 
diagnosis of 
anaphylactic 
shock due to 
peanut, ICD-9 
code 995.61 
Yes Anaphyla
xis 
admissio
n   
4/5 
Mullins 
2010 
(40) 
Australia 
2002-
2007  
Australia 
population 
National 
hospitalization 
database: ICD-
10 code T78 
Yes Anaphyla
xis 
admissio
n   
4/5 
A
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Foucard 
1999 
(36) 
Sweden 
1993-
1996 
Swedish 
population 
Survey of 
physicians, with 
case notes 
scrutinized by a 
single 
investigator  
No Anaphyla
xis 
admissio
n   
 
1/5 
 
 
Calvani 
2008 
(34) 
Lazio, 
Italy 
2000-
2003 
Lazio 
population 
aged 0-17 
Hospital and 
emergency 
department 
information 
system: ICD 
codes 995.0, 
995.6, 995.4, 
999.4 for 
admissions; ICD 
codes 708.0, 
989.5, 995.0, 
995.2, 995.3, 
995.4, 995.6, 
999.4 for 
fatalities. 
Yes Anaphyla
xis 
admissio
n   
 
4/5 
 
 
 
Nocerin
o 
2011(43
) 
Italy, 
2001-
2005 
Italy 
population 
aged 0-14 
National hospital 
discharge 
database: ICD-9 
codes: 99560, 
99561, 99562, 
99563, 99564, 
99565, 99567, 
99568, 99569. 
Yes Anaphyla
xis 
admissio
n   
4/5 
Ho 
2009 
(44) 
Hong 
Kong 
2006-
2007 
Hong Kong 
population 
aged 0-18 
Hospital 
discharge 
database: ICD-9 
codes 995.0, 
995.1, 995.6 
Yes Anaphyla
xis 
admissio
n   
3/5 
*Quality assessment based on a modified Newcastle-Ottawa scale for Cohort Studies 
[8] 
† Original data kindly provided by study authors 
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Table 2. Food anaphylaxis incidence rates for food allergic people - calculated using different 
estimates for food allergy prevalence. 
 Estimated food allergy prevalence Event rate - mean 
(95%CI) 
Medically coded food 
anaphylaxis  
(events per 100 person years) 
All ages: 2% 0.21   (0.08, 0.53) 
All ages: 4% 0.11   (0.04, 0.26) 
All ages: 6% 0.07   (0.03, 0.18) 
Age 0-19: 2% 0.39   (0.18, 0.84) 
 Age 0-19: 3.9% 0.20   (0.09, 0.43) 
 Age 0-19: 10.4% 0.08   (0.03, 0.16) 
 Age 0-4: 2% 0.72   (0.02, 33.29) 
 Age 0-4: 3.9% 0.37 (0.01, 17.07) 
 Age 0-4: 10.4% 0.14   (0.00, 6.40) 
Hospital admissions for food 
anaphylaxis  
(events per 1000 person 
years) 
All ages: 2% 0.14  (0.02, 0.10) 
All ages: 4% 0.07  (0.01, 0.50) 
All ages: 6% 0.05  (0.01, 0.03) 
Age 0-19: 2% 0.39  (0.20, 0.84) 
 Age 0-19: 3.9% 0.20  (0.10, 0.43) 
 Age 0-19: 10.4% 0.08  (0.04, 0.16) 
 Age 0-4: 2% 0.98  (0.51, 1.81) 
 Age 0-4: 3.9% 0.50 (0.26, 0.93) 
 Age 0-4: 10.4% 0.19  (0.10, 0.35) 
 
Estimated prevalence rates are taken from the meta-analysis of Rona et al. (2), for symptoms of 
food allergy and a positive allergy test, or for some estimates from more recent studies (1, 8). 
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Table 3. Summary of estimated food anaphylaxis rates for food allergic people. 
Anaphylaxis definition Age group Estimated annual incidence rate 
Self-reported food anaphylaxis All ages Less than 1 episode every 10 person 
years 
Aged 0-19 * Less than 1 episode every 10 person 
years 
Medically coded food 
anaphylaxis 
All ages Less than 1 episode every 300 person 
years 
Aged 0-19 Less than 1 episode every 250 person 
years 
Aged 0-4 Less than 1 episode every 5 person 
years 
Hospital admissions for food 
anaphylaxis 
All ages Less than 1 episode every 1000 
person years 
Aged 0-19 Less than 1 episode every 2000 
person years 
Aged 0-4 Less than 1 episode every 1000 
person years 
 
* Data are from follow up studies of food allergic patients seen in allergy clinics. One 
small study found a higher rate of anaphylaxis (1 episode every 1.7 years (14)).
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Figure Legends 
Figure 1. PRISMA flow chart showing results of literature search. 
Figure 2. Estimated rate of medically coded food anaphylaxis (A), or hospital admission 
for food anaphylaxis (B) for a food allergic person, expressed as incidence rate per 100 
person years (A) or per 1000 person years (B). 
Figure 3. Estimated rate of self-reported (A) or medically coded (B) food anaphylaxis, or 
hospital admission for food anaphylaxis (C) for a food allergic person aged 0-19, 
expressed as incidence rate per 100 person years (A, B) or per 1000 person years (C). 
Figure 4. Estimated rate of medically coded (A) food anaphylaxis, or hospital admission 
for food anaphylaxis (B) for a food allergic person aged 0-4, expressed as incidence 
rate per 100 person years (A) or per 1000 person years (B). 
Figure 5. Estimated rate of self-reported (A) or medically coded (B) peanut anaphylaxis, 
or hospital admission for peanut anaphylaxis (C)  for a peanut allergic person, 
expressed as incidence rate per 100 person years (A, B) or per 1000 person years (C). 
Figure E1. Funnel plot to assess risk of publication bias in analysis of self-reported food 
anaphylaxis incidence rate at age 0-19. 
Figure E2. Estimated risk of food anaphylaxis for a food allergic person (A) or food 
allergic person aged 0-19 (B), compared with other general population risks. Continuous 
bar represents mean with 95% confidence interval; dotted bar is the range of point 
estimates from individual studies. Where reference risks vary markedly between 
European and United States populations, they are stated separately. Otherwise 
reference risks are for a United States population. 
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